APP and Alzheimer disease: For instance, in the animal model of AD, peripheral administration of lipopolysaccharide increased BBB permeability, brain IL-6 levels, and sickness behaviour in amyloid precursor protein (APP)-transgenic mice, suggesting that peripheral inflammation might spread to the brain through permeable BBB and affect the severity of behavioural problems in AD APP-transgenic mice [52].